Shanghai Kaibao Pharmaceutical Co., Ltd. Class AShanghai Kaibao Pharmaceutical Co., Ltd. Class AShanghai Kaibao Pharmaceutical Co., Ltd. Class A

Shanghai Kaibao Pharmaceutical Co., Ltd. Class A

No trades
Market capitalization
‪6.34 B‬CNY
0.33CNY
‪375.58 M‬CNY
‪1.46 B‬CNY
‪916.40 M‬
Beta (1Y)
0.98
Employees (FY)
‪1.23 K‬
Change (1Y)
−100 −7.55%
Revenue / Employee (1Y)
‪1.19 M‬CNY
Net income / Employee (1Y)
‪306.59 K‬CNY

About Shanghai Kaibao Pharmaceutical Co., Ltd. Class A


CEO
Ying Bin Zhou
Website
Headquarters
Shanghai
Founded
2000
IPO date
Jan 8, 2010
IPO offer price
5.57USD
Identifiers
2
ISINCNE100000JZ3
Shanghai Kaibao Pharmaceutical Co., Ltd. engages in the research & development, production, and sale of Chinese medicine. It offers medicines are in the form of injection, tablets, hard capsules, and granules. Its products are used for treatment of cardiovascular and cerebrovascular, respiratory, and digestive diseases. The company was founded on April 12, 2000 and is headquartered in Shanghai, China.

Check out other big names from the same industry as 300039.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
560010
GF CSI 1000 Exchange Traded Fund Units
Weight
0.05%
Market value
‪2.31 M‬
USD
159647
Penghua CSI Traditional Chinese Medicine ETF
Weight
0.95%
Market value
‪979.37 K‬
USD
159680
CMF CSI 1000 Enhanced Strategy Exchange Traded Fund
Weight
0.66%
Market value
‪383.51 K‬
USD
159633
E Fund CSI 1000 ETF
Weight
0.05%
Market value
‪126.17 K‬
USD
160119
China Southern CSI 500 ETF
Weight
0.00%
Market value
‪24.14 K‬
USD
159377
Guotai GEM Health Care Index ETF Units
Weight
0.69%
Market value
‪21.40 K‬
USD
560110
China Universal CSI 1000 Exchange Traded Fund Units
Weight
0.05%
Market value
‪18.10 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 300039 is 6.13 CNY — it has increased by 0.33% in the past 24 hours. Watch Shanghai Kaibao Pharmaceutical Co., Ltd. Class A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange Shanghai Kaibao Pharmaceutical Co., Ltd. Class A stocks are traded under the ticker 300039.
300039 stock has fallen by −3.49% compared to the previous week, the month change is a −6.32% fall, over the last year Shanghai Kaibao Pharmaceutical Co., Ltd. Class A has showed a −6.27% decrease.
300039 reached its all-time high on Jun 15, 2015 with the price of 19.00 CNY, and its all-time low was 3.70 CNY and was reached on Feb 4, 2021. View more price dynamics on 300039 chart.
See other stocks reaching their highest and lowest prices.
300039 stock is 1.16% volatile and has beta coefficient of 0.98. Track Shanghai Kaibao Pharmaceutical Co., Ltd. Class A stock price on the chart and check out the list of the most volatile stocks — is Shanghai Kaibao Pharmaceutical Co., Ltd. Class A there?
Today Shanghai Kaibao Pharmaceutical Co., Ltd. Class A has the market capitalization of ‪6.36 B‬, it has decreased by −4.13% over the last week.
Yes, you can track Shanghai Kaibao Pharmaceutical Co., Ltd. Class A financials in yearly and quarterly reports right on TradingView.
300039 net income for the last quarter is ‪65.09 M‬ CNY, while the quarter before that showed ‪37.66 M‬ CNY of net income which accounts for 72.82% change. Track more Shanghai Kaibao Pharmaceutical Co., Ltd. Class A financial stats to get the full picture.
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A dividend yield was 1.62% in 2024, and payout ratio reached 27.85%. The year before the numbers were 1.50% and 31.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 19, 2025, the company has ‪1.23 K‬ employees. See our rating of the largest employees — is Shanghai Kaibao Pharmaceutical Co., Ltd. Class A on this list?
Like other stocks, 300039 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Shanghai Kaibao Pharmaceutical Co., Ltd. Class A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Shanghai Kaibao Pharmaceutical Co., Ltd. Class A technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Shanghai Kaibao Pharmaceutical Co., Ltd. Class A stock shows the sell signal. See more of Shanghai Kaibao Pharmaceutical Co., Ltd. Class A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.